Clinical Trial Update: Venlafaxine Augmentation in Treatment Resistant Depression [Phase 4]

View source ↗

Summary

Phase 4 trial assessing venlafaxine augmentation for treatment-resistant depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Venlafaxine (Venlafaxine)

Snippet

Sponsor: Max-Planck-Institute of Psychiatry | Conditions: Depression | Phase 4 | Status: COMPLETED